Read more from the New York Times about the US FDA's major shift in positon over BPA. The agency announced last Friday that it had “some concern about the potential effects of BPA on the brain, behavior and prostate gland of fetuses, infants and children,” and would join other federal health agencies in studying the chemical in both animals and humans.